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Abstract—Induced pluripotent stem cell derived cardiomy-
ocytes (iPSC-CM) provide a powerful platform for disease
modeling and drug development in vitro. Traditionally,
electrophysiological methods or ﬂuorescent dyes (e.g. cal-
cium) have been used in their functional characterization.
Recently, video microscopy has enabled non-invasive anal-
ysis of CM contractile motion. Simultaneous assessments of
motion and calcium transients have not been generally
conducted, as motion detection methods are affected by
changing pixel intensities in calcium imaging. Here, we
present for the ﬁrst time a protocol for simultaneous video-
based measurement of contraction and calcium with ﬂuores-
cent dye Fluo-4 videos without corrections, providing data
on both ionic and mechanic activity. The method and its
accuracy are assessed by measuring the effect of ﬂuorescence
and background light on transient widths and contraction
velocity amplitudes. We demonstrate the method by showing
the contraction-calcium relation and measuring the transient
time intervals in catecholaminergic polymorphic ventricular
tachycardia patient speciﬁc iPSC-CMs and healthy controls.
Our validation shows that the simultaneous method provides
comparable data to combined individual measurements,
providing a new tool for measuring CM biomechanics and
calcium simultaneously. Our results with calcium sensitive
dyes suggest the method could be expanded to use with other
ﬂuorescent reporters as well.
Keywords—Biomechanics, Fluorescence, Motion analysis,
Calcium-contraction coupling.
ABBREVIATIONS
CaPIV Calcium particle image velocimetry
CD Contraction duration
CM Cardiomyocyte
CPVT Catecholaminergic polymorphic ventricu-
lar tachycardia
CTD Calcium transient duration
hiPSC Human induced pluripotent stem cell
iPSC Induced pluripotent stem cell
iPSC-CM Induced pluripotent stem cell derived car-
diomyocyte
PIV Particle image velocimetry
RYR Cardiac ryanodine receptor
MQD Minimum quadratic difference
WT Wild type
INTRODUCTION
Cardiovascular diseases represent the leading cause
of death globally. Additionally, adverse eﬀects of car-
dioactive and non-cardiac drugs remain the most
common reason for market withdrawal. Induced
pluripotent stem cell derived cardiomyocytes (iPSC-
CM) have presented a promising platform for both
disease modeling and drug development with healthy
and patient speciﬁc cells. These studies have been tra-
ditionally done using electrical measurements, while
methods for measuring mechanical function of cells
without extensive instrumentation have only recently
been emerging. High throughput methods for drug
screening with iPSC-CMs are needed, as the large
variability in electrophysiological results regarding
iPSC-CM bring about the need for a greater number of
experiments.15 These methods could be used in addi-
tion for development of personalized therapy for ge-
netic cardiac diseases, such as catecholaminergic
polymorphic ventricular tachycardia (CPVT).10
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The commonly used methods for analyzing elec-
trophysiological functions of cardiomyocytes (CM)
include calcium imaging,18 patch clamping8,11 and
microelectrode array11 studies. However, these mea-
surements often require manual operation by trained
personnel and thus are not well suited towards high-
throughput applications. In addition, while the ionic
function they measure control the mechanical function
of the CMs, the resulting signals do not relate directly
to the resulting biomechanics that is the actual CM
functional aspect. CM biomechanics has traditionally
been measured in vitro using atomic force
microscopy,19 mechanical transduction with microp-
osts4,22 and traction force microscopy.21 Video-based
methods have been developed and studied by us1,2,9
and by several other groups.6,7,14 As the method is
non-invasive and has easy to use instrumentation, vi-
deo analysis has good high-throughput capabilities.
Calcium imaging can be used as a powerful tool for
high throughput proﬁling of drug responses in vitro. In
CMs, calcium plays a key role as a second messenger
of excitation contraction coupling. Drug effects are
reﬂected as changes in calcium transient proﬁle. With
ﬂuorescent calcium reporter dyes, either small mole-
cule or genetically encoded, it is possible to visualize
and record calcium ﬂuxes inside CMs. Special high
throughput imaging apparatuses, for example Hama-
matsu FDSS,3 allow simultaneous reading of calcium
transients from up to hundreds of samples. These
platforms can be used to study several disease models
and drugs in a short time period compared to con-
ventional microscopes. High content screening pro-
duces large amount of data, which require automated
software for handling and analyzing the massive
amounts of data.17
The major beneﬁt of human iPSC (hiPSC) in CM
studies is their power to provide CMs from speciﬁc
phenotypes. Here CPVT cells was selected as targeted
application example for our novel methodology.
CPVT is a rare but severe inherited cardiac disease in
structurally normal hearts, which may lead to sudden
cardiac death. CPVT patients experience arrhythmias
during mental or physical stress. CPVT is associated
with mutations in RYR2 gene, coding for cardiac
ryanodine receptor (RYR), among few other disease-
associated genes. Therapy includes drug treatment
with beta-blockers, implantable cardiac deﬁbrillators
or left cardiac sympathetic denervation.23 The calcium
abnormalities arising from mutations in RYR2 reﬂect
to contractile motion of CMs. Therefore, CPVT
speciﬁc iPSC-CMs are interesting platform to study
not only calcium kinetics but also the contractile mo-
tion simultaneously.
So far, the ionic and mechanical functions have been
studied simultaneously using speciﬁc platforms, such
as on microposts.4,22 Video-based measurements,
however, do not require such systems: microscopes and
video cameras are typical laboratory instruments,
which as such enable video-based measurements.
Methods to provide combined ionic and biomechanic
assessment of the CMs could offer novel avenues to
look into disease mechanisms and drug effects. Previ-
ously, it has not been able to track motion in bright
ﬁeld microscopy simultaneously with ﬂuorescent re-
porters due to the effects of ﬂuorescent induced
changes in pixel intensity on the motion detection
methods. In previous studies the ﬂuorescence back-
ground has been subtracted from images with mixed
phase-contrast and ﬂuorescence.6 In another study,
calcium reporter GCaMP6f –gene was used and
simultaneous measurement was conducted with com-
puted local intensity normalization in each interroga-
tion window to counteract the effect of the intensity
changes.7
In this study, we combine concurrent calcium
imaging with our previously developed video analysis
method, which uses minimum quadratic diﬀerence
(MQD) based particle image velocimetry (PIV) and
assess biomechanical and ionic function simultane-
ously from videos of ﬂuorescent calcium imaging. As
in the MQD method we used1 sets equal weight to all
image pixels,5 we hypothesized that the method could
work also in calcium imaging by increasing back-
ground lighting conditions to make motion more vis-
ible. To verify our hypothesis, consecutive frames with
ﬂuorescent calcium dye excitation and transmission
channels were measured with two background light
levels. We validated the method by comparing con-
traction and calcium transient widths as well as PIV
amplitudes from frames with and without the ﬂuores-
cent excitation, and with and without background
light. We demonstrated the method by measuring the
relation of contraction and calcium in wild type (WT)
and CPVT cells, and calculated the time interval
between the maximum signal onset and offset rates of
change in both signals.
MATERIALS AND METHODS
Patient-Speciﬁc Human iPSC Lines
Details on hiPSC culturing and CM diﬀerentiation
are available in supplements.
In this study both normal control CMs and diseased
CMs prone to arrhythmias were used. The diseased
CPVT cells were derived from patients having muta-
tions in RYR2 gene, associated with structural changes
in RYR, resulting in abnormal release of Ca2+ from
sarcoplasmic reticulum and increased ventricular
arrhythmias when heart rate increases. Two CPVT
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patient speciﬁc hiPSC lines were used:
UTA.05605.CPVT carrying exon 3 deletion and
UTA.05404.CPVT carrying V4563F mutation in
RYR2 gene (referred to as CPVTa and CPVTb
respectively). UTA.04602.WT cell line was used as a
control. The collection of biopsies for generating pa-
tient speciﬁc hiPSC lines was approved by the ethical
committee of Pirkanmaa Hospital District (Aalto-Se-
ta¨la¨ R08070) and written informed consent was
obtained from all the donors.
Imaging Protocol
Details on imaging protocol are available in sup-
plements.
CMs plated on glass coverslips were loaded with
Fluo-4 AM. Imaging was done using Olympus IX71
inverted microscope with Polychrome V and TH4-200
light sources and Andor iXon 885 EMCCD camera.
Cells were perfused with warmed (37 C) perfusate
medium. Two channels were recorded consecutively:
the Olympus light source was turned on to obtain vi-
deo image while still being able to discern Ca2+ ﬂuc-
tuations. The recording process is illustrated in Fig. 1a.
In total, 25 videos were recorded: 7 CPVTa, 5 CPVTb
and 13 WT videos. The recordings were all baseline
measurements.
Video Data Processing
The obtained recordings, consisting of video imag-
ing and calcium imaging data with light source oﬀ and
on, were categorized and processed. The region of
interest for each recording was selected based on both
intensity of the calcium ﬂuctuations and observed
motion.
MQD based PIV, as described previously,1,2,9 was
used for determining velocity vector ﬁelds in the video
image series. The process was applied to both trans-
mission and calcium imaging with background light on,
resulting in two series of velocity vector ﬁelds from
which motion signals are calculated: one from the
frames with only visible light—traditional PIV mea-
surement—and another from the frames with ﬂuores-
cent emission of calcium indicator, deﬁned as calcium
PIV (CaPIV). Only the frames with light source on were
included in these sets. Calcium signals were calculated
from the pixel intensity in each frame. With respect to
the light source status, two consecutive data series were
obtained: calcium with ﬂuorescent light from Poly-
chrome V—Ca (dark)—and calcium with light from
both Polychrome V and Olympus TH4-200 (transmis-
sion) - Ca (bright). With this method, four signal types
were obtained—two from both modalities: calcium and
motion. The process is illustrated in Fig. 1a.
Using our previously described method, shortly, the
directional motion signals indicating contraction and
relaxation velocities were obtained from velocity vec-
tor ﬁelds by determining a CM beating focus point.
The motion directed towards it was deﬁned as radial
movement and the perpendicular motion as tangential,
resulting in motion signals. As opposed to the previous
article, each vector was divided in these components
with respect to their location. The same region of
interest was used for calcium imaging. Further, con-
traction signals were calculated from the motion sig-
nals by integration with respect to time. Linear
detrending was applied to the resulting signals to cor-
rect the baseline.
As a non-ratiometric dye was used and absolute
contraction amplitude was not assessed, calcium,
contraction and motion signals were all normalized to
interval [0,1] by linear rescaling for visualization. The
motion signal baseline was then set to zero, with con-
traction being positive and relaxation negative. For
calcium and contraction signals, one beat long cross-
FIGURE 1. Imaging protocol, processing of the video channels and definition of transient duration parameters. (a) Fluorescent
calcium and visible light were recorded in consecutive frames. Midway during the recording, light source was turned on to
increase the background light intensity, allowing video signal to be captured. Traditional PIV was measured from the frames with
only visible light and CaPIV signal was measured from frames with calcium fluorescence present. Calcium signal was categorized
based on the background light intensity to Ca (dark) and Ca (bright). (b) Transient duration parameters are defined as percentages
from the peak maximum, similarly as when classifying action potentials.
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correlation based averaged signal templates were cal-
culated, as described earlier.2 The averaging was syn-
chronized based on the maximum rate of change
during the onset of the contraction or transient. A
correlation coefﬁcient of 0.5 was used to exclude only
the most abnormal beats.
Signal Comparison
The similarity of the recorded signals was measured
by determining parameters describing the waveform
widths and amplitudes. The duration of the contrac-
tion in the templates was characterized by calculating
contraction duration (CD) parameters and the dura-
tion of calcium by calcium transient duration (CTD)
parameters. The durations at percentages of the max-
imum peak height were deﬁned as shown in Fig. 1-
b—an approach similar to characterization of action
potentials. The used parameters were CD10, CD25,
CD50, CD80 and CD90, representing the width of the
peak at each percentage measured from the peak in
each waveform. For calcium, the same CTD parame-
ters were determined, respectively.
Temporal diﬀerences between the contraction and
calcium transient were measured using the combined
signals from the maximum rate of change in the onset
and oﬀset of CaPIV and Ca (bright). As the calcium
transients may have several peaks of diﬀerent heights,
this approach was selected instead of comparing the
time diﬀerence between peaks themselves.
Statistics
Mean values and standard deviations of CDs and
CTDs, as well as temporal diﬀerences between con-
traction and calcium were calculated. CDs and CTDs
were tested against each other using a two-sample t test
with all combinations of PIV, CaPIV, Ca (dark) and
Ca (bright). In addition, durations fromWT cell videos
(n = 13) were tested against those measured from
CPVT cell videos (CPVTa n = 7, CPVTb n = 5)
regarding all combinations of signal types from the
same modality—calcium and motion. Waveform
amplitude similarity was determined by calculating the
symmetric mean absolute percentage error of con-
traction motion velocity magnitudes of each contrac-
tion in PIV and CaPIV signals. Linear regression was
used to map width parameters against the other signal
types, and their similarity was estimated using linear
regression R2 parameter. P-values below 0.05 were
considered statistically signiﬁcant. The statistical
analysis was performed in MATLAB R2014a, The
Mathworks, Inc.
RESULTS
Beating Characteristics
For WT, the average beating rate was 22 beats per
min with a ± 10.8 standard deviation. For CPVTa and
CPVTb the values were 20.7 ± 12.9 and 12.2 ± 5.6
beats per min, respectively. The number of beats in
CPVT videos were lower than in WT videos as some
videos only had two beats with the background light
on/oﬀ.
Representative Signals
Representative signals with synchronized motion
(CaPIV) and calcium signals (Ca (bright)) were calcu-
lated. For each cell line, both motion and contraction
signals are shown with overlaid calcium transients in
Fig. 2. In motion signals (left side), an upward peak
signiﬁes contractile and downward peak relaxation
movement velocity. Motion signal is used for illus-
trating the ﬁne details of the movement. Contraction
signal (right side)—the integral of the motion signal
with respect to time—shows displacement during a
contraction. The contraction signal enables easier
comparison of calcium and contraction. For this
illustration, the signals were linearly normalized sepa-
rately for visualization.
In the visual inspection of the displacement and
calcium signals from studied WT cell populations,
contraction started only after increase in calcium
transient had started. Contraction signals typically had
a steeper oﬀset slope than calcium, which had a longer
tail, and started to fall slightly earlier. In CPVTa cells,
in some signals motion followed the calcium transient
with a longer delay than in WT. No evident afterde-
polarizations or tailing of calcium was present in the
signals. In CPVTb, the contraction signal started to
fall slightly later than the calcium transient.
Method Validation
The simultaneous recording method was validated
by comparing signals obtained from PIV (motion from
videos without ﬂuorescence), CaPIV (motion from vi-
deos with ﬂuorescence), Ca (bright) (calcium with
background light) and Ca (dark) (without background
light) signals. CTD parameters from the two calcium
signals, CD parameters from the two contraction sig-
nals, and amplitudes from the two motion velocity
signals were calculated.
PIV and CaPIV did not show statistically signiﬁcant
diﬀerences between the means of CD parameters. This
can be seen in Fig. 3, where the overlaid CaPIV (in
blue) and PIV (red) show a very similar curve, with
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minor deviations showing near the baseline. Similarly,
Ca (bright) and Ca (dark) did not exhibit signiﬁcant
differences in CTD parameters. This indicates that no
major differences were induced by the change in
lighting to enable the combined signal measurement.
The symmetric mean absolute percentage errors
between PIV and CaPIV contraction velocity ampli-
tudes were calculated for the contractions in each
recording. The diﬀerence was found to be
6.42 ± 3.44% in WT, 4.11 ± 5.01% in CPVTa and
2.73 ± 1.57% in CPVTb. The total error for all
recordings was 5.04 ± 3.87%.
Assessment of Cell Line Functions Using Simultaneous
Contraction and Calcium
Contraction and Calcium Signal Characteristics
The widths of the contraction peak in CaPIV and
the calcium transient Ca (bright) in the simultaneous
measurement were characterized by parameters indi-
cating their duration at percentages of the peak max-
imum height. The CD- and CTD-parameters were
calculated at signal levels 10, 25, 50, 80 and 90 and
shown in Table 1.
In both CD and CTD parameters, the standard
deviation was very high indicating high variance within
the cell lines.
Similarity of Signals Between Modalities
Linear regressions between pairs of contrac-
tion/calcium transient durations for the four diﬀerent
signals were calculated. The results are shown in
Table 2. Pairs of the same modality (leftmost tables)
FIGURE 2. Representative motion (left side) and displacement (right side) signals plotted over calcium transients for the three
cell lines. In the motion signals, the contractile movement velocity is represented with and upward peak and the relaxation
movement velocity as a downward peak in red, while calcium transient is shown in blue. In the displacement signals (right side),
representing the motion velocity signal integral with respect to time, contraction is shown in red and calcium transient in blue.
Representative signals are shown for the three cell lines.
FIGURE 3. A representative displacement measurement
showing overlaid CaPIV (blue) with fluorescence and PIV
(shown in red) without fluorescence.
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show high R2 values: PIV exhibits very high coefﬁcient
of determination (R2) values with CaPIV in both WT
and CPVT cells. Only in CD90 the value of CPVTb R2
was below 0.9. Likewise, high R2 values were obtained
from regression between Ca (bright) and Ca (dark)
even though the signals were not concurrent like mo-
tion signals. In calcium, R2 values below 0.9 were seen
in CPVTa CTD25 and CTD90, and a relatively low
value in CTD10 of CPVTb. Low R2 values were typi-
cally seen in cross-modality pairs near the baseline
(CD/CTD80 and CD/CTD90), especially in CPVTa.
These results indicate the simultaneous measurement
works well—the signals of the same modality are in-
deed very similar in shape. Further, the simultaneous
motion and calcium measurements show a disconnec-
tion of calcium and motion in CPVT lines—especially
CPVTa—which is not evident in calcium measure-
ments.
Calcium-Motion Coupling
The concurrent calcium-contraction measurement
allows the measurement of synchronicity in calcium
and motion dynamics. Here, we looked at the temporal
diﬀerences between these signals by calculating the
time points of maximum rate of change in the onsets
and oﬀsets of calcium transient and motion from Ca
(bright) and CaPIV, respectively. The obtained values
are shown in Table 3.
Positive time values in onset and oﬀset indicate that
motion signal is following the calcium transient. Some
negative values in oﬀset were obtained indicating that
motion reached its peak relaxation velocity before
maximum calcium decline velocity. In Table 3 this is
indicated by large standard deviation compared to the
offset value especially for CPVTa. Although CPVTa
shows a higher onset and CPVTb a higher offset in
mean times, the ﬁndings are not statistically signiﬁcant
due to the large variability. Also these results reveal
that CPVTa and CPVTb show different contraction-
calcium coupling dynamics from WT but also different
from each other.
The diﬀerence between the means of motion and
calcium signal parameters was statistically signiﬁcant
in WT in all parameters (p< 0.05 in CD/CTD10,
p< 0.01 in the remaining parameters), but not in
CPVTa or CPVTb. This ﬁnding shows that measure-
ments of motion and calcium provide complementary
information and insight on the Ca2+ and contraction
coupling dynamics.
When comparing the cell lines, the motion modali-
ties PIV and CaPIV did not exhibit signiﬁcant diﬀer-
ences between the contraction durations of WT and
CPVT cell lines. However, calcium modalities Ca
(bright) and Ca (dark) showed signiﬁcant diﬀerences
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between means of WT and CPVTb in CTD80 and
CTD90. Neither calcium nor motion modalities dis-
played signiﬁcant diﬀerences between WT and CPVTa.
DISCUSSION
We developed and demonstrated a method for
simultaneous CM motion and calcium transient
recording from ﬂuorescent videos. The method uses
simultaneous application of both transmission and
ﬂuorescent light source. In traditional methods the
calcium based ﬂuorescent signal could represent a
source of error for PIV analysis and further, the
brightﬁeld imaging could aﬀect the calcium imaging
transients. We tested the method susceptibility to both
error sources by separating these factors with inter-
lacing brightﬁeld and ﬂuorescent video frames and
observed that a simultaneous measurement of calcium
and contraction is feasible.
We recorded consecutive frames of brightﬁeld
imaging and calcium ﬂuorescent imaging in iPSC-CMs
on video, with background light on and oﬀ. Four
diﬀerent signals were obtained: motion from bright-
ﬁeld video (PIV), motion from video with ﬂuorescence
(CaPIV), calcium imaging without background light
(Ca (dark)) and calcium imaging with background
light (Ca (bright)). We characterized the signals for
both validation and demonstration of the method.
With this procedure, we aimed to demonstrate that
CM contraction could be quantiﬁed reliably while
running a simultaneous ﬂuorescent measurement.
Further, we demonstrated the usefulness of the
simultaneous measurement by comparing the calcium
and contraction signals, calculating time intervals
between calcium and motion, and analyzing the dif-
ferences between WT and two diﬀerent CPVT cell
lines.
Eﬀect of Fluorescent Light on Motion Analysis
Previously, the intensity changes caused by ﬂuores-
cence have prevented simultaneous motion measure-
ments. MQD, however, does not put emphasis on
bright pixels thus making it a plausible method for the
task. Our results show that the intensity ﬂuctuation
eﬀect by ﬂuorescent light is negligible to both timing
and magnitude of the motion signal. This is the ﬁrst
time such measurement and assessment of accuracy
TABLE 2. Linear regression of CD and CTD parameters.
PIV/CaPIV PIV/Ca (bright) CaPIV/Ca (bright)
WT CPVTa CPVTb WT CPVTa CPVTb WT CPVTa CPVTb
10 0.983 0.997 0.975 0.663 0.128 0.430 0.698 0.136 0.511
25 0.943 0.997 0.996 0.737 0.540 0.897 0.698 0.537 0.888
50 0.965 0.997 0.995 0.637 0.731 0.732 0.612 0.684 0.752
80 0.967 0.991 0.976 0.640 0.129 0.451 0.630 0.091 0.384
90 0.966 0.989 0.817 0.710 0.000 0.186 0.724 0.003 0.057
Ca (bright)/Ca (dark) PIV/Ca (dark) CaPIV/Ca (dark)
WT CPVTa CPVTb WT CPVTa CPVTb WT CPVTa CPVTb
10 0.914 0.913 0.567 0.518 0.138 0.958 0.525 0.150 0.945
25 0.939 0.753 0.859 0.685 0.605 0.834 0.612 0.616 0.793
50 0.951 0.970 0.991 0.552 0.741 0.742 0.507 0.702 0.760
80 0.968 0.946 0.992 0.573 0.155 0.539 0.564 0.119 0.473
90 0.950 0.778 0.961 0.686 0.070 0.274 0.685 0.111 0.082
Linear regression between the contraction (CD)/calcium transient durations (CTD) at percentages of the maximum peak height (10, 25, 50, 80
and 90) for each pair of measured signals.
TABLE 3. Time intervals between calcium and contraction.
WT CPVTa CPVTb
Ca (bright) and CaPIV difference on onset 163 ± 132 ms 238 ± 136 ms 126 ± 102 ms
Ca (bright) and CaPIV difference on offset 40 ± 91 ms 24 ± 142 ms 113 ± 75 ms
Mean time differences and standard deviations between the calcium transient and contraction in different cell lines, in milliseconds. The
differences between cell lines are not statistically significant.
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have been done without using corrections with a ﬂu-
orescent dye.
Our results indicate that MQD based analysis of
CM motion is minimally aﬀected by the presence of a
ﬂuorescence based measurement. In t-tests, there were
no signiﬁcant diﬀerences between the means of mea-
sured CD parameters. The R2 values in linear regres-
sion studies between normal brightﬁeld PIV and
CaPIV with ﬂuorescence were very high in all three cell
lines indicating the very low impact of ﬂuorescence
presence. There were small differences in the lower
parts of the peaks as well as a minor 5% difference in
magnitudes of contraction velocities. We believe this
measurement setup allows measuring of motion with a
variety of different ﬂuorescent indicators, as long as
movement is present. Determining a sufﬁcient level of
lighting for the measurements may be a key factor in
the acquisition of two simultaneous high quality
recordings.
Eﬀect of Bright Light on Calcium Imaging
Applying transmission light had only small eﬀect on
the calcium imaging waveforms. In linear regression
analysis, high R2 values were obtained between Ca
(bright) and Ca (dark), in all three cell lines. However,
in CPVT some lower regression values were obtained
due to a number of possible factors: calcium transients
Ca (bright) and Ca (dark) were not from the same
beats, the number of recorded cells in CPVT lines was
low and as the beating rate was lower, the number of
beats in each signal was smaller than in WT. As
illustrated in the CPVTa signals shown in Fig. 2, the
calcium transients could have multiple small peaks (i.e.
arrhythmias/abnormal transients) making the direct
comparison of peak width parameters difﬁcult. For
WT cells, the peaks were more regular and Ca (bright)
and Ca (dark) were both capable of characterizing the
cell lines similarly, as shown in t-tests. Ca (dark) and
Ca (bright) amplitudes were not compared, as the
comparison would not have been valid due to the
bleaching of ﬂuorescent dye during the measurement.
Moreover, it is evident that increased background light
increases the background noise level in ﬂuorescence
measurement. However, sufﬁcient transmission light or
constant ﬂuorescent light is needed for detection of
motion signal from the video. At the same time, the
ﬂuorescent emission of the dye should be strong en-
ough to be detected while the transmission video is
acquired. Increasing the light intensity or exposure
time of the sample may not be the best solutions since
they result in higher photobleaching of ﬂuorophores
and slower frame rates.
Ratiometric dyes have diﬀerent emission spectra for
bound and unbound states with the indicated ion, for
example with Fura-2. Therefore, it takes two consec-
utive channel recordings to capture the ratio between
these states, which takes longer and results in lower
frame rates in acquisition. In this case, as an additional
channel for brightﬁeld video is measured, non-ratio-
metric dyes, such as Fluo-4, are better since their
emission needs to be recorded only on one wavelength
rather than ratiometric dyes. The results indicate that
in calcium studies, with a focus on the waveforms in-
stead of absolute Ca2+ concentration, it is feasible to
apply also the brightﬁeld light to obtain additional
information on the mechanical activity without
affecting the calcium measurement.
Cell Line Diﬀerences
There was no statistically signiﬁcant diﬀerences in t-
tests between motion in WT and CPVT cell lines when
considering PIV or CaPIV. CPVT cells typically pre-
sent arrhythmias under adrenergic stimulation, but as
only the baseline beating is analyzed here, the motion
signals correspond to those of WT. These results would
indicate that the CPVT cells do not directly exhibit
beating phenotypes different from WT cells at baseline
conditions. Earlier, using PIV we have found differing
beating phenotypes in LQT cells, but of course also the
clinical presentation of the diseases are different.9
Ca (bright) and Ca (dark) showed statistically sig-
niﬁcant diﬀerences between WT and CPVTb in CTD80
and CTD90, but not between WT and CPVTa. These
diﬀerences could be caused by a higher variation in
diastolic calcium levels in CPVTb caused by a leakage
of calcium through RYRs in the cells. However, the
amplitude of these diastolic events is so low compared
to the actual calcium peak so there were no diﬀerences
in the parameters associated with the higher parts of
the peak (i.e. CTD10).
The combination of motion and calcium measure-
ments showed a varying disconnection of the two, as
shown by the R2 values (Table 2) especially for
CPVTa. The most prevalent cause for CPVT lies in
mutations in RYR2 gene coding for RYR.20 It is lo-
cated at the membrane of sarcoplasmic reticulum in
CMs and acts as a channel releasing calcium from
sarcoplasmic reticulum to cytosol. Mutations in RYR2
cause spontaneous calcium leakage through the chan-
nel and altered calcium transients inside CMs.13 In
CPVTb population, which carries a V4653F mutation
in RYR, the substituted amino acid is located in the
channel domain of the protein.16 It is thought to be a
gain-of-function point mutation, as most of the RYR
mutations, and alter the channels sensitivity or per-
meability to calcium ions.23 CPVTa population, which
carries an exon 3 deletion, has the structural defect on
the cytosolic part of the protein in the N-terminal
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domain and is associated with more severe clinical
outcome.12 The difference in the nature of these two
mutations could explain the differences in our results.
The disconnection between calcium and beating mo-
tion could be related to the earlier ﬁnding by Tang
et al. where the exon 3 deletion was found to be
resulting in an abnormal termination of calcium re-
lease through the RYR.24
Simultaneous Calcium and Motion Measurements
The combined simultaneous recording of motion
and calcium as shown here provides new tools for
studying the CM contraction mechanism. In t-tests
between motion and calcium modalities, statistical
diﬀerences were seen in WT cell lines, but not in
CPVTa/CPVTb. The lack of statistical diﬀerence
between motion and calcium in CPVT was surprising
and it may again be caused by the low number of
recorded cells or more heterogeneous beating patterns
and calcium transients. In linear regression analysis of
motion and calcium modalities, represented in Table 2,
CPVTa had lower R2 values than WT and CPVTb:
there was practically no relation between the mea-
surements in peak parameters characterizing the low
amplitudes.
Mean time diﬀerences of signal onset and oﬀset rate
of change maxima did not show statistically signiﬁcant
diﬀerences between the cell lines due to high variability
and low number of cells measured. However, CPVTa
did show indication of longer time intervals between
calcium and motion in onset, and CPVTb in oﬀset.
Overall, the results indicate that calcium and motion
go hand in hand as is expected, but one cannot directly
be deduced from the other. Although the low corre-
lation values in CPTVa may be caused by the low
number of samples, high correlation values were not
present for WT either where the sample number was
higher. This reinforces the idea that even if Ca2+ is the
driving force in CM contraction, calcium measurement
alone cannot be used to describe the mechanical
function in full detail. Further, motion alone does not
necessarily reﬂect the ionic functions, emphasizing the
need for the combined method suggested here as a new
tool for CM analysis.
Method Advantages
Video-based measurements are minimally invasive
and have low instrumentation requirements. These
aspects make them a feasible candidate for high-
throughput studies. For laboratories, this method can
be used in conjunction with other studies, as micro-
scopes and video cameras are mainstay laboratory
equipment. The threshold for including contraction
measurements in studies is lower than measurements
with other methods, because no additional equipment
is needed. Combining the method with ﬂuorescent
beads, substrate deformation and thus contraction
force could be measured as well. While here we have
considered individual cells and small clusters, the
method should be applicable for larger samples of
cardiac tissue, as long as 2-dimensional approach is
still feasible. As we have shown here, the possibility of
measuring CM contraction from calcium imaging data
also enables revisiting previous studies and expanding
on their results.
Study Limitations and Sources of Error
To validate the method we used interlaced video.
The time diﬀerence between PIV and CaPIV vi-
deos—by being consecutive frames and the relatively
low frame rate—must be taken into account when
estimating their diﬀerences and similarities. The frame
interlacing produces intrinsic time diﬀerences of 21.7
and 8.8 ms for our minimum frame rate 46 and max-
imum frame rate 114, respectively. A higher frame rate
with slow beating cells would give a more accurate
reading. However, the observed diﬀerences between
normal brightﬁeld PIV and ﬂuorescence CaPIV were
small, indicating that MQD-based motion measure-
ments are minimally obstructed by ﬂuorescence sig-
nals. We have previously explored waveform averaging
in brief,2 suggesting a frame rate of 60. Further studies
with a higher frame rate and more beats per video
would better quantify the difference in amplitudes for
measurements where absolute precision of magnitude
is required. Due to the low number of recordings, the
ﬁndings related to the disconnection between calcium
and motion in CPVT cells should be considered ten-
tative. A study focusing on calcium-motion coupling in
CPVT cells is required for reliability.
In this study, CMs were cultured on glass coverslips
where their morphology is diﬀerent from mature
human CMs. Therefore, results may be diﬀerent using
i.e. patterned CMs. However, our method should be
applicable to those studies also.
Our method uses simultaneous optimized trans-
mission and ﬂuorescent light sources. The results
showed that the added light source had very small ef-
fect on the detected ﬂuorescent signal. However, the
method is producing additional light load to the ﬂuo-
rescent dye and cells and thus photobleaching of the
dye and phototoxicity should be considered. As our
method uses no ﬂuorescent signal background correc-
tion, it is straightforward to compute and free from
possible correction errors.
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CONCLUSION
We have developed and evaluated a protocol for
simultaneous calcium and motion signal measurement.
By measuring the same motion from videos with and
without ﬂuorescence, we were able to validate and
quantify the accuracy of a simultaneous measurement.
Our results show that MQD based PIV is minimally
aﬀected by ﬂuorescence. Furthermore, by measuring
the calcium transients with and without background
light, we showed that simultaneous brightﬁeld imaging
causes minimal interference to the calcium measure-
ment. This is the ﬁrst time simultaneous measurements
of video-based CM motion with ﬂuorescent dye based
calcium transients are conducted without ﬂuorescent
video background corrections. It opens a new avenue
to study the simultaneous ionic and biomechanical
functions and the diﬀerences in their dynamics.
Our demonstration of simultaneous measurement
implies that combined imaging is applicable also with
other ﬂuorescent reporters. Combining the measure-
ment of motion would provide an additional layer of
information for ﬂuorescence studies. All these will
open a new door to greater understanding of elec-
tromechanical coupling in CM contraction, disease
mechanisms and drug eﬀects.
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